Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janet Allen is active.

Publication


Featured researches published by Janet Allen.


Brain Research | 1987

Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurones in vitro

P.A. Brooks; John S. Kelly; Janet Allen; D.A.S. Smith; Trevor W. Stone

Intracellular recordings from granule cells of the rat dentate gyrus show neuropeptide Y (NPY) applied by pressure ejection from pipettes containing 1.2-12 microM by pressures of less than 200 kPa for 1-5 s in duration to consistently evoke membrane depolarisations accompanied by a reduction in membrane resistance. The depolarisations were accompanied by an increase in excitability. Since the depolarisations evoked by NPY were not attenuated by either tetrodotoxin or kynurenic acid a direct excitatory action of NPY is postulated.


Brain Research | 1989

Neuropeptide Y (NPY) and vasopressin (AVP) in the hypothalamo-neurohypophysial axis of salt-loaded or Brattleboro rats.

Shing Chuan Hooi; Gary S. Richardson; John K. McDonald; Janet Allen; Joseph B. Martin; James I. Koenig

A close anatomical relationship between nerve terminals containing neuropeptide Y (NPY) and vasopressin (AVP) has been demonstrated in the hypothalamic paraventricular (PVN) and supraoptic nuclei (SON). Furthermore, injections of NPY into the SON increased plasma concentrations of AVP in the rat. These data suggest a potential involvement of hypothalamic NPY in fluid homeostasis in the rat. Therefore, we have studied the effect of elevated plasma osmolality on the concentration of NPY and AVP in the hypothalamus and neurointermediate lobe (NIL) of the pituitary gland. Furthermore, we measured the concentration of NPY in the AVP-deficient Brattleboro rat, which suffers from diabetes insipidus and hyperosmolality. Salt-loading increased plasma osmolality and the concentration of AVP from 2.0 +/- 0.5 to 4.1 +/- 0.6 pg/ml after 7 days. The concentration of NPY in the NIL doubled after 7 days of salt-loading, from 7.9 +/- 0.6 ng/mg protein to 15.2 +/- 1.4 ng/mg protein, whereas AVP concentrations fell from 2285.7 +/- 210.9 ng/mg protein to 187.5 +/- 2.5 ng/mg protein. AVP concentrations in the ME increased transiently after 2 days of salt-loading and returned to control levels after 7 days. In contrast, NPY concentrations in the ME were unchanged at 2 days and were increased 61% after 7 days. NPY concentrations also were significantly elevated after 7 days of salt-loading in the preoptic area (POA) and mediobasal hypothalamus (MBH). The concentration of NPY in the NIL of the homozygous Brattleboro rat was 2-fold greater than in the heterozygous Brattleboro rat and 4-fold greater than in Sprague-Dawley rats used as controls.(ABSTRACT TRUNCATED AT 250 WORDS)


Neuroscience Letters | 1989

Sex differences in vasoactive intestinal peptide (VIP) concentrations in the anterior pituitary and hypothalamus of rats

Peter N. Riskind; Janet Allen; Steven M. Gabriel; James I. Koenig; Judith Audet-Arnold

Recent evidence suggests that vasoactive intestinal peptide (VIP), a putative prolactin (PRL)-releasing factor, is both synthesized and released by anterior pituitary cells, to act as a paracrine or autocrine factor. We have investigated the hypothesis that hypothalamic or pituitary VIP levels differ in male and female rats, since neuroendocrine control of PRL is sexually differentiated. Opposite sex differences were found in the hypothalamus and anterior pituitary. Random-cycle female rats had one-third higher VIP levels in the hypothalamus than males. In contrast, anterior pituitary VIP levels were 3 times as high in male rats as in females. Median eminence VIP levels were similarly low in both sexes. These results support a possible role of VIP in the sexually dimorphic regulatory mechanisms of PRL secretion. Moreover, demonstration that hypothalamic and pituitary VIP levels vary in opposite directions suggests that VIP is differentially regulated at the two sites.


Archive | 1989

DNA encoding CD40

Janet Allen; Alejandro Aruffo; David Camerini; Leander Dr. Lauffer; Carmen Oquendo; David Simmons; Ivan Stamenkovic; Siegfried Stengelin


Archive | 1995

CD40 coding sequences

Brian Seed; Janet Allen; Alejandro Aruffo; David Camerini; Leander Dr. Lauffer; Carmen Oquendo; David Simmons; Ivan Stamenkovic; Siegfried Stengelin; Martine Amiot


CONFERENCE ON CENTRAL AND PERIPHERAL SIGNIFICANCE OF NEUROPEPTIDE Y AND ITS RELATED PEPTIDES ( 1990 : BALTIMORE, MARYLAND ) | 1990

Central and peripheral significance of neuropeptide Y and its related peptides

Janet Allen; James I. Koenig


Archive | 1989

DNA encoding CD 19

Brian Dr. Seed; Janet Allen; Alejandro Aruffo; David Camerini; Carmen Oquendo; David Simmons; Ivan Stamenkovic; Leander Dr. Lauffer; Siegfried Dr. Stengelin


Archive | 1989

CD40 kodierende DNA CD40-encoding DNA

Brian Seed; Janet Allen; Alejandro Aruffo; David Camerini; Leander Dr. Lauffer; Carmen Oquendo; David Simmons; Ivan Stamenkovic; Siegfried Stengelin


Archive | 1989

Dna que codifica cd 19.

Brian Seed; Janet Allen; Alejandro Aruffo; David Camerini; Carmen Oquendo; David Simmons


Archive | 1989

Dna que codifica cd40.

Brian Seed; Janet Allen; Alejandro Aruffo; David Camerini; Leander Dr. Lauffer; Carmen Oquendo

Collaboration


Dive into the Janet Allen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brian Seed

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge